About this trial
This study looks at how to involve American Indians from Southwestern Tribal Nations in cancer genome sequencing. These communities experience higher rates of certain cancers, such as liver, kidney, breast, and colon cancers. The goal is to learn how genetic changes can lead to cancer and improve prevention and treatment options for these populations. Researchers aim to create respectful and effective ways to engage American Indians affected by cancer in this research.
The trial ID is NCT06207864. It is not FDA-regulated and aims to enroll about 1,001 participants. This is a health services research study.
Who can join
This trial is open to adults aged 18 and older who self-identify as American Indian and are currently undergoing cancer treatment or are cancer survivors. People who are cognitively impaired, unable to consent for themselves, under 18 years old, or prisoners cannot join. The trial team will confirm who is eligible.
Condition
Malignant Neoplasm
Age group
Adult, Older adult
The study team makes the final call on eligibility.
What happens in the study
Participants will provide tissue, blood, saliva, and stool samples for genomic sequencing and microbiome analysis. They will also complete surveys and participate in interviews both before and after the study. Everyone will be involved in this process as the study does not use random group assignments.
Where
This trial is running at 1 location in the United States. It is currently recruiting.
University of New Mexico Comprehensive Cancer Center
Albuquerque, New Mexico